News from Sutro Biopharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 11, 2017, 08:00 ET Sutro Marks Two Drug Development Milestones

Sutro Biopharma has received a manufacturing milestone payment from Celgene and has completed production of STRO-001, its first...


Aug 10, 2017, 08:00 ET Sutro & Celgene to Refocus 2014 Immuno-Oncology Collaboration on Four Programs

Sutro Biopharma today announced it is refocusing its 2014 immuno-oncology collaboration with Celgene on four programs that are advancing through...


Jul 17, 2017, 08:00 ET New Evidence of Sutro ADC's Potency in Human Tumor Xenografts

STRO-001, Sutro Biopharma's antibody drug conjugate targeting the CD74 cell surface protein in hematologic B-cell malignancies, has been shown to...


Sep 07, 2016, 08:00 ET Sutro Marks Important Progress -- Receives Two Milestone Payments from Celgene

 Sutro Biopharma Inc. today announced that it has received two milestone payments from drug discovery and development partner Celgene...


Jun 01, 2016, 08:00 ET Sutro Appoints Shabbir T. Anik Chief Technical Operations Officer

 Sutro Biopharma today announced the appointment of Dr. Shabbir T. Anik to the newly-created position of chief technical operations officer....


Mar 09, 2016, 10:00 ET Sutro Expands Senior Leadership Team with Addition of Chief Medical Officer and VP of Translational Pharmacology and Preclinical Development

 Sutro Biopharma today announced the appointment of Arturo Molina, M.D., M.S., FACP as chief medical officer and Mark Lupher, Ph.D., as vice...


Nov 18, 2015, 09:00 ET Sutro Biopharma Receives the Pantheon 2015 DiNA Outstanding Partner Award by the California Life Sciences Association

 Sutro Biopharma today announced that it was awarded the Outstanding Partner Award, at the California Life Sciences Association (CLSA) annual...


Oct 23, 2014, 07:30 ET Sutro Biopharma and Celgene Corporation Enter Multi-Year Strategic Collaboration and Option to Acquire Agreement

 Sutro Biopharma today announced it has entered into a strategic collaboration and option agreement with Celgene Corporation to discover and...


Sep 22, 2014, 08:00 ET FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014

 Sutro Biopharma today announced that it has been named by FierceBiotech as one of 2014's Fierce 15 biotechnology companies, designating it as...


Sep 17, 2014, 08:00 ET Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates

Sutro Biopharma, a biopharmaceutical company developing antibody drug conjugates and bispecific antibodies, and the biopharmaceutical division of...


Sep 09, 2014, 09:00 ET Sutro Biopharma to Collaborate with University of California, San Francisco (UCSF), a Recombinant Antibody Network (RAN) Member

Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug...


Mar 24, 2014, 09:00 ET Sutro Biopharma to Present at 21st Annual Future Leaders in the Biotech Industry Conference

 Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug...


Jan 07, 2014, 09:00 ET Sutro Biopharma to Collaborate With Memorial Sloan-Kettering Cancer Center to Produce Bispecific Antibodies for the Treatment of Neuroblastoma

 Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug...


Dec 11, 2013, 09:00 ET Sutro Biopharma Closes $26 Million Financing, Expands Development of Novel Immuno-Oncology Products

Sutro Biopharma today announced that the company has secured $26 million in a Series D financing. The additional financing will fund the expansion...


Oct 15, 2013, 14:00 ET Sutro Biopharma Presents Dual-Warhead Antibody Drug Conjugate at the World ADC Summit

 Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics utilizing Sutro's cell-free protein synthesis...


Jan 31, 2013, 09:00 ET Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer

Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics utilizing Sutro's cell-free protein synthesis...


Jan 03, 2013, 09:00 ET Sutro Biopharma to Collaborate with Sanofi Pasteur on a Novel Production Approach for Vaccine Candidates

Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics utilizing Sutro's cell-free protein synthesis...


Oct 24, 2012, 09:00 ET Sutro Biopharma Expands Senior Management Team

 Sutro Biopharma, a biopharmaceutical company developing a new generation of antibody drug conjugate therapeutics and bifunctional...


Jun 14, 2012, 09:00 ET Sutro Licenses "Click Chemistry" from The Scripps Research Institute

 Sutro Biopharma today announced that it has signed a licensing agreement with The Scripps Research Institute and will have access to "click...


May 08, 2012, 07:30 ET Sutro Closes $16.5 Million Second Tranche of Series C Financing

 Sutro Biopharma today announced the closing of the $16.5 million second tranche of its Series C financing. This financing was led by Skyline...


Jan 07, 2012, 09:00 ET Sutro Announces Newly Formed Scientific Advisory Board

Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties,...


Oct 17, 2011, 09:00 ET Sutro Biopharma to Present its Biochemical Protein Synthesis Technology at BioProduction Conference 2011 in Berlin

Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today...


May 19, 2011, 09:00 ET Study Shows Sutro Biopharma's Biochemical Protein Synthesis Technology Enables Rapid Production and Scale-Up of Biopharmaceuticals

Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today...


Jan 07, 2011, 09:00 ET Sutro Biopharma Forges Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide-Based Therapeutics

Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today...


Dec 08, 2010, 09:00 ET Sutro Biopharma Appoints Trevor Hallam, Ph.D., as Chief Scientific Officer

Sutro Biopharma, a biopharmaceutical company developing both novel and biosuperior protein therapeutics with improved pharmaceutical properties,...